Presented at PVRI's Drug Discovery & Development Symposium 2025, Anna Hemnes (Vanderbilt University Medical Center) and Hossein Ardeschir Ghofrani (University Hospital Giessen)
Telehealth utilization increased during the coronavirus disease-2019 (COVID-19) pandemic, which encouraged remote patient management. The identification of optimal strategies to enhance telehealth and address barriers to its use for patients with pulmonary arterial hypertension (PAH) may improve patient outcomes.
